Prevention, personalization, and empathy take center stage in these 15 bold predictions for the biggest research-driven breakthroughs of 2026.

BCI® Therapy is being developed to restore thought-driven movement in people living with spinal cord injuries and other ...

OpenAI is continuing its push into healthcare by investing in Merge Labs, a brain computer interface startup co-founded by its CEO, Sam Altman. Merge Labs is a competitor in the brain computer ...

The team thinks this means that the cingulate cortex manages the social purpose and context of the facial gesture, which is ...

As the momentum and interest in brain-computer interface (BCI) technologies continue to accelerate, Merge Labs has emerged ...

In August, the Financial Times reported that OpenAI Chief Executive Officer Sam Altman is part of Merger Labs’ founding team ...

Merge Labs is a “research lab” dedicated to “bridging biological and artificial intelligence to maximize human ability.” ...

An important milestone has been achieved in brain-computer interface (BCI) technology. A new peer-reviewed study published in Nature Biomedical Engineering shows how a high-performance brain-computer ...

The Cerelog ESP-EEG is an 8-channel, low-cost brain computer interface (BCI) circuit board built around the ESP32 MCU and designed for EEG data acquisition. The board supports 8-channel, 24-bit EEG ...

Brain–computer interfaces are beginning to truly "understand" Chinese. The INSIDE Institute for NeuroAI, in collaboration with Huashan Hospital affiliated with Fudan University, the National Center ...

In 2025, China’s non-invasive brain–computer interface (BCI) technology passed a critical test—not in a lab, but in the real world. Researchers validated the technology in two very different, ...

OpenAI CEO Sam Altman’s new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles–based nonprofit Forest Neurotech, according to a source with direct knowledge of the ...